IndiaTickerAarti Pharmalabs Ltd - 543748 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026.BSE · financial results · pdf
Source filing Company dossier
Aarti Pharma Labs
NSE:AARTIPHARM · ISIN INE0LRU01027
- Close
- ₹682.95 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Aarti Pharma Labs
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Aarti Pharmalabs LimitedNSE · exchange filing · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Press Release - Aarti Pharmalabs LimitedNSE · exchange filing · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Trading Window - Aarti Pharmalabs LimitedNSE · exchange filing · pdf
Source filing Allotment of Securities - Aarti Pharmalabs LimitedNSE · exchange filing · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSBSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Aarti Pharmalabs LimitedNSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Aarti Pharmalabs LimitedNSE · exchange filing · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Aarti Pharmalabs LimitedNSE · conference call · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Copy of Newspaper Publication - Aarti Pharmalabs LimitedNSE · exchange filing · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · audio
Source filing Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Audited Financial Results For The Quarter And Financial Year Ended March 31, 2026BSE · financial results · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Aarti Pharmalabs LimitedNSE · conference call · pdf
Source filing Investor Presentation - Aarti Pharmalabs LimitedNSE · investor presentation · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Board Meeting Outcome for Approval Of Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended On 31 March 2026 And Recommending Final Dividend.BSE · financial results · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Re-Appointment Of Cost Auditor & Internal Auditor For FY 2026-2027BSE · exchange filing · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Corporate Action-Board to consider DividendBSE · corporate action · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Grant Of Options Under 'APL Performance Stock Option Plan- 2023'BSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Aarti Pharmalabs LimitedNSE · financial results · pdf
Source filing General Updates - Aarti Pharmalabs LimitedNSE · exchange filing · pdf
Source filing Change in Management - Aarti Pharmalabs LimitedNSE · exchange filing · pdf
Source filing ESOP/ESOS/ESPS - Aarti Pharmalabs LimitedNSE · exchange filing · pdf
Source filing Dividend - Aarti Pharmalabs LimitedNSE · exchange filing · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Aarti Pharmalabs LimitedNSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Aarti Pharmalabs LimitedNSE · conference call · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Update on board meetingBSE · exchange filing · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Board Meeting Intimation for Approval Of The Audited Financial Results For The Quarter And Financial Year Ended March 31, 2026 And Recommendation Of Final Dividend, If Any.BSE · financial results · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing